Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation.

Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation. Abstract Text:

Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation. Publishing Authors By Initials

For similar biological phenomena, cell phenomena, and immunity: immunity: immunity, cellular: transplantation immunology research abstracts see: biological phenomena, cell phenomena, and immunity: immunity: immunity, cellular: transplantation immunology research

PUBMED ID PMID:

MEDLINE DATE:

Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation. Journal Published:

PUBLICATION TYPE: Review

Journal: Journal of the American Geriatrics Society

VOLUME: 14

Page Numbers: 716-30

Journal Abbreviation: J Am Geriatr Soc

ISSN: 0002-8614

DAY: 10

MONTH: Jul

YEAR: 1966

Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation. Information

Number of References: 29

LANGUAGE: eng

NlmUniqueID: 7503062

Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation. Keywords Mesh Terms:

KEYWORDS: Transplantation Immunology

MESH TERMS: immunology

Chemical & Substance for Abstract: Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Am Geriatr Soc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Host-tumor antagonism XXXVI Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation Related Publications

• Burning sensation of the tongue, (glossodynia); an analysis of cases that are not due to vitamin B deficiency.
• HOST-TUMOR ANTAGONISM. 32. THE EPIDEMIOLOGY OF CANCER.
• HOST-TUMOR ANTAGONISM. 33. CANCER IMMUNITY--A REVIEW AND AN ANALYSIS OF SOME FACTORS IN HOST RESISTANCE TO CANCER.
• Host-tumor antagonism. I. Evidence for the existence of tumor immunity.
• Host-tumor antagonism. II. Hormone dependency of certain cancers.
• Host-tumor antagonism. III. Prolonged survival of certain patients with cancer; fortuitous occurrence or immunity mechanism?
• Host-tumor antagonism. IV. Immunologic possibilities inherent in some of the theories on the nature of cancer.
• Host-tumor antagonism. V. The effect of ionizing radiations (radium and x-ray) upon tumor and host.
• Host-tumor antagonism. 23. The hereditary aspects of cancer.
• Host-tumor antagonism. 27. Nutrition and cancer.
• Host-tumor antagonism. 28. Thoughts on the constitution of a cancer vaccine.
• Host-tumor antagonism. X. Radiation; a double-edged sword.
• Host-tumor antagonism. XI. Recapitulation of various aspects: practical applications of this knowledge to the care of patients.
• Host-tumor antagonism. XIX. Cancer and dysfunction of the liver.
• Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma.
• Host-tumor antagonism. XVI. The effect of one disease upon another.
• Host-tumor antagonism. XVII. Trauma and cancer.
• Host-tumor antagonism. XX. The influence of pregnancy on tumor growth.
• Host-tumor antagonism. XXI. Rationale of the use of gestational products (including placental extracts) in the therapy of cancer.
• Host-tumor antagonism. XXII. The skin as an immunologic organ.
• Host-tumor antagonism. XXIV. The latent period in the formation of cancer: the "cancer-age" myth.
• Host-tumor antagonism. XXV. The carcinogens in our midst.
• Host-tumor antagonism. XXVI. The controversy on smoking and lung cancer: application of Occam's razor and Loeb's law.
• Host-tumor antagonism. XXXV. Some important aspects of cancer.
• Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation.
• Restoration of diuretic response with triamcinolone in refractory cardiac edema.
• The action of neostigmine in supraventricular tachycardias.
• The conservative therapy of endometriosis of the colon with the use of testosterone; report of a case.
• The inactivation of estrogens by lipotropic substances; studies of liver dysfunction.
• The relationship of upper respiratory infections to congestive heart-failure in patients with heart disease.